Efgartigimod Followed by Telitacicept in Adult Generalized Myasthenia Gravis: A Retrospective Case Series
This regimen demonstrated favorable efficacy and safety, suggesting its potential as an effective option for gMG management.
Authors
- Qiaoyi Zhang
- Bingbing Wan
- Jia Li (ORCID: https://orcid.org/0000-0002-8216-2163)
- Shengli Pan (ORCID: https://orcid.org/0000-0002-1904-6557)
- Yu Zhang (ORCID: https://orcid.org/0000-0003-3474-422X)
- Yaping Liu (ORCID: https://orcid.org/0000-0002-1076-9046)
- Yuan Zhang (ORCID: https://orcid.org/0009-0003-5998-1544)
- Shuya Yang
- Xu Zhang (ORCID: https://orcid.org/0009-0004-4086-9541)
- Yi Dai
- Zheyu Fang
- Xi Long Qu
Institutions
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Huaian First People’s Hospital (CN)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2025-04-01
- DOI
- https://doi.org/10.2147/jir.s513986
- Citations
- 2
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 2.78
Funders
- National Natural Science Foundation of China